Vimarsana
Biggest News Aggregation in the World

Kenneth Saag News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kenneth Saag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kenneth Saag Today - Breaking & Trending Today

Pegloticase Treatment Associated with Concomitant Bone Remodeling in Gout - Vimarsana News

Pegloticase Treatment Associated with Concomitant Bone Remodeling in Gout

Kenneth Saag, MD, explores the clinical significance of a study demonstrating treatment with pegloticase leads to bone remodeling in patients with gout.

UAB researchers secure PCORI funding to compare two pathways of post-fracture patient care - Vimarsana News

UAB researchers secure PCORI funding to compare two pathways of post-fracture patient care

In osteoporosis, bones become brittle and fragile, putting them at high risk of fractures or breaks. These "fragility fractures" can cause pain, suffering, disability and even death, and patients have increased risks of repeat fractures.

Osteoporosis: UAB-led study approved for a $13.9 million award to investigate prevention of bone fractures - Vimarsana News

Osteoporosis: UAB-led study approved for a $13.9 million award to investigate prevention of bone fractures

The study, funded by the Patient-Centered Outcomes Research Institute, will compare two pathways of post-fracture patient care. The study, funded by the Patient-Centered Outcomes Research Institute, will compare two path...

Source: uab.edu
Rheumatology Month in Review: July 2023 - Vimarsana News

Rheumatology Month in Review: July 2023

The rheumatology month in review features studies exploring ways to enhance care, an increased risk of adverse COVID-19 outcomes, and pegloticase plus methotrexate co-therapy for gout treatment.

Kenneth Saag, MD: Pegloticase and Methotrexate Concomitant Therapy Demonstrates Continued Benefits for Gout Treatment - Vimarsana News

Kenneth Saag, MD: Pegloticase and Methotrexate Concomitant Therapy Demonstrates Continued Benefits for Gout Treatment

At the 12-month mark, response rate in patients with uncontrolled gout was significantly higher in those treated with pegloticase and concomitant methotrexate when compared with placebo.